Anbio Biotechnology (NNNN) stock price, chart and financials

Price chart

Revenue (trailing twelve months)

$8.6M

Revenue (quarter)

$8.6M

Revenue growth (year over year)

+5.64%

Gross profit (trailing twelve months)

$7.5M

Gross margin

87.24%

Net income (trailing twelve months)

$6.4M

Net income (quarter)

$6.4M

Net income growth (year over year)

+169.86%

Net margin

74.06%

Return on equity

27.05%

EPS (trailing twelve months)

$0.15

Book value per share

$0.21

P/E (trailing twelve months)

160.79

Price to book

34.14

Debt to assets

0.29%

Payout ratio

—

Dividend yield

—

• Is Anbio Biotechnology (NNNN) profitable?

  Yes. Anbio Biotechnology earned $6.4M in net income over the trailing twelve months, a net margin of 74.06%.

• How much revenue does Anbio Biotechnology (NNNN) make?

  Anbio Biotechnology generated $8.6M in revenue over the trailing twelve months, up 5.64% year over year.

• What is NNNN's P/E ratio?

  Anbio Biotechnology trades at 160.8 times trailing twelve-month earnings, on an EPS of $0.15.

• How do I buy stock in Anbio Biotechnology (NNNN)?

  NNNN trades commission-free with a Light Horse Securities brokerage account — from the mobile app, the web dashboard at portal.lighthorse.io, the trading API, or an AI agent connected over MCP. The trade panel on this page places the order once you are signed in.